- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genenta Science SpA ADR (GNTA)
Genenta Science SpA ADR stock price live, this page displays NASDAQ GNTA stock exchange data. View the GNTA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genenta Science SpA ADR real time stock price chart below.
What Is the Genenta Science SpA ADR Stock Price Today?
The Genenta Science SpA ADR stock price today is 2.010.
What Is the Stock Symbol for Genenta Science SpA ADR?
The stock symbol for Genenta Science SpA ADR is ""GNTA.""
What Stock Exchange Does Genenta Science SpA ADR Trade On?
Genenta Science SpA ADR is listed and trades on the NASDAQ stock exchange.
Is Genenta Science SpA ADR a Good Stock to Buy?
Determining whether Genenta Science SpA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNTA quote. (ISIN: US36870W1009)
What Is the Genenta Science SpA ADR Stock Price Today?
The Genenta Science SpA ADR stock price today is 2.010.
What Is the Stock Symbol for Genenta Science SpA ADR?
The stock symbol for Genenta Science SpA ADR is ""GNTA.""
What Stock Exchange Does Genenta Science SpA ADR Trade On?
Genenta Science SpA ADR is listed and trades on the NASDAQ stock exchange.
Is Genenta Science SpA ADR a Good Stock to Buy?
Determining whether Genenta Science SpA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNTA quote. (ISIN: US36870W1009)
NASDAQ
Currency in USD
2.010
+0.070(+3.61%)
Closed·
Fair Value
An estimate of a Genenta Science ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.990
2.180
52 wk Range
1.350
10.000
GNTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Genenta Science ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.9902.180
52 wk Range
1.35010.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNTA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Genenta Science ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
20.725
Upside
+931.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Genenta Science prices $15 million share offering
- Investing.com
- Form 6K Genenta Science SpA ADR For: 28 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Genenta Science SpA ADR Company Profile
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Compare GNTA to Peers and Sector
Metrics to compare | GNTA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNTAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.7x | −1.5x | −0.6x | |
PEG Ratio | −1.15 | 0.02 | 0.00 | |
Price/Book | 3.4x | 1.2x | 2.6x | |
Price / LTM Sales | - | 14.1x | 3.3x | |
Upside (Analyst Target) | - | 53.5% | 38.7% | |
Fair Value Upside | Unlock | 4.7% | 3.2% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 20.725
(+931.08% Upside)
Earnings
Latest Release
Oct 10, 2025
EPS / Forecast
-0.20 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Genenta Science ADR (GNTA) Premarket Price Today?
The Genenta Science ADR (GNTA) premarket price is 2.000. Premarket price change units: 0.060. Premarket percentage change: 3.090%. Premarket volume: 4,500.000. Current date: 29 Nov 2025. Previous close: 1.940
What Stock Exchange Does Genenta Science ADR Trade On?
Genenta Science ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Genenta Science ADR?
The stock symbol for Genenta Science ADR is "GNTA."
What Is the Genenta Science ADR (GNTA) Afterhours Price Today? (Afterhours variable test: 2.000) Current Date: 29 Nov 2025
After hours price: 2.000. After hours price change (units): 0.060. Price change percentage: 3.090%
What Is the Genenta Science ADR Market Cap?
As of today, Genenta Science ADR market cap is 47.10M.
What Is Genenta Science ADR's Earnings Per Share (TTM)?
The Genenta Science ADR EPS (TTM) is -0.47.
From a Technical Analysis Perspective, Is GNTA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Genenta Science ADR Stock Split?
Genenta Science ADR has split 0 times.
How Many Employees Does Genenta Science ADR Have?
Genenta Science ADR has 13 employees.
What is the current trading status of Genenta Science ADR (GNTA)?
As of 29 Nov 2025, Genenta Science ADR (GNTA) is trading at a price of 2.010, with a previous close of 1.940. The stock has fluctuated within a day range of 1.990 to 2.180, while its 52-week range spans from 1.350 to 10.000.
What Is Genenta Science ADR (GNTA) Price Target According to Analysts?
The average 12-month price target for Genenta Science ADR is USD20.72472171, with a high estimate of USD20.72472171 and a low estimate of USD20.72472171. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +931.08% Upside potential.
What Is the GNTA Premarket Price?
GNTA's last pre-market stock price is 2.000. The pre-market share volume is 4,500.000, and the stock has decreased by 0.060, or 3.090%.
What Is the GNTA After Hours Price?
GNTA's last after hours stock price is 2.000, the stock has decreased by 0.060, or 3.090%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.